Cargando…

Apolipoprotein A-I exchange is impaired in metabolic syndrome patients asymptomatic for diabetes and cardiovascular disease

OBJECTIVE: We tested the hypothesis that HDL-apolipoprotein A-I exchange (HAE), a measure of high-density lipoprotein (HDL) function and a key step in reverse cholesterol transport (RCT), is impaired in metabolic syndrome (MetSyn) patients who are asymptomatic for diabetes and cardiovascular disease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borja, Mark S., Hammerson, Bradley, Tang, Chongren, Savinova, Olga V., Shearer, Gregory C., Oda, Michael N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540550/ https://www.ncbi.nlm.nih.gov/pubmed/28767713 http://dx.doi.org/10.1371/journal.pone.0182217

Ejemplares similares

HDL-apoA-I Exchange: Rapid Detection and Association with Atherosclerosis
por: Borja, Mark S., et al.
Publicado: (2013)

Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome
por: Savinova, Olga V., et al.
Publicado: (2014)

The secondary structure of apolipoprotein A-I on 9.6-nm reconstituted high-density lipoprotein determined by EPR spectroscopy
por: Oda, Michael N, et al.
Publicado: (2013)

Apolipoprotein A-I Attenuates Palmitate-Mediated NF-κB Activation by Reducing Toll-Like Receptor-4 Recruitment into Lipid Rafts
por: Cheng, Andrew M., et al.
Publicado: (2012)

Conformational flexibility of apolipoprotein A-I amino- and carboxy-termini is necessary for lipid binding but not cholesterol efflux
por: Bedi, Shimpi, et al.
Publicado: (2022)

Factors controlling nascent high-density lipoprotein particle heterogeneity: ATP-binding cassette transporter A1 activity and cell lipid and apolipoprotein AI availability
por: Lyssenko, Nicholas N., et al.
Publicado: (2013)

The Association between Apolipoprotein A-II and Metabolic Syndrome in Korean Adults: A Comparison Study of Apolipoprotein A-I and Apolipoprotein B
por: Yi, Dong Won, et al.
Publicado: (2012)

Cardiovascular Screening in Asymptomatic Adolescents with Metabolic Syndrome
por: Bae, Hyun Kyung, et al.
Publicado: (2015)

Lipid-bound apolipoproteins in tyrosyl radical-oxidized HDL stabilize ABCA1 like lipid-free apolipoprotein A-I
por: Hossain, Mohammad A, et al.
Publicado: (2012)

Effects of inflammation and soluble epoxide hydrolase inhibition on oxylipin composition of very low‐density lipoproteins in isolated perfused rat livers
por: Walker, Rachel E., et al.
Publicado: (2021)

Apolipoprotein A-I and Cancer
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2015)

On the Aggregation of Apolipoprotein A-I
por: Frankel, Rebecca, et al.
Publicado: (2022)

Apolipoprotein B in cardiovascular risk assessment
por: Ahmad, Maud, et al.
Publicado: (2023)

Apolipoprotein A-I anti-tumor activity targets cancer cell metabolism
por: Zamanian-Daryoush, Maryam, et al.
Publicado: (2020)

Apolipoprotein E allele 4 effects on Single-Subject Gray Matter Networks in Mild Cognitive Impairment
por: Sanabria-Diaz, Gretel, et al.
Publicado: (2021)

Vitamin K antagonists and cardiovascular calcification: A systematic review and meta-analysis
por: Kosciuszek, Nina D., et al.
Publicado: (2022)

Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness
por: Huang, Fei, et al.
Publicado: (2013)

Definition of Human Apolipoprotein A-I Epitopes Recognized by Autoantibodies Present in Patients with Cardiovascular Diseases
por: Teixeira, Priscila Camillo, et al.
Publicado: (2014)

Inducing apolipoprotein A-I synthesis to reduce cardiovascular risk: from ASSERT to SUSTAIN and beyond
por: Di Bartolo, Belinda A., et al.
Publicado: (2016)

Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly
por: Haan, Mary N., et al.
Publicado: (2010)

Long-term consumption of artificial sweeteners does not affect cardiovascular health and survival in rats
por: Guru, Satvinder K., et al.
Publicado: (2022)

Association of Impaired Vascular Endothelial Function with Increased Cardiovascular Risk in Asymptomatic Adults
por: Zhong, Qiuan, et al.
Publicado: (2018)

The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity
por: Kaneva, Anastasiya M., et al.
Publicado: (2015)

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)

Apolipoprotein A-I modulates HDL particle size in the absence of apolipoprotein A-II
por: Melchior, John T., et al.
Publicado: (2021)

Apolipoprotein A-I vascular gene therapy reduces vein-graft atherosclerosis
por: Bi, Lianxiang, et al.
Publicado: (2023)

Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease
por: Olofsson, Sven-Olof, et al.
Publicado: (2007)

CHOLESTEROL METABOLISM IN THE MACROPHAGE : I. THE REGULATION OF CHOLESTEROL EXCHANGE
por: Werb, Zena, et al.
Publicado: (1971)

Apolipoprotein E impairs aged bone fracture healing
por: Balu, Abhinav, et al.
Publicado: (2021)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
por: Mahley, Robert W.
Publicado: (2016)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

Association between cognitive impairment and apolipoprotein A1 or apolipoprotein B levels is regulated by apolipoprotein E variant rs429358 in patients with chronic schizophrenia
por: Rao, Wenwang, et al.
Publicado: (2021)

Importance of Apolipoprotein A-I in Multiple Sclerosis
por: Gardner, Lidia A., et al.
Publicado: (2015)

Effect of an isoenergetic traditional Mediterranean diet on apolipoprotein A-I kinetic in men with metabolic syndrome
por: Richard, Caroline, et al.
Publicado: (2013)

Simultaneous Mass Spectrometry-Based Apolipoprotein Profiling and Apolipoprotein E Phenotyping in Patients with ASCVD and Mild Cognitive Impairment
por: Begcevic Brkovic, Ilijana, et al.
Publicado: (2022)

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021)

Association of the Apolipoprotein B/Apolipoprotein A-I Ratio, Metabolic Syndrome Components, Total Cholesterol, and Low-Density Lipoprotein Cholesterol with Insulin Resistance in the Population of Georgia
por: Makaridze, Zaza, et al.
Publicado: (2014)

Novel N-terminal mutation of human apolipoprotein A-I reduces self-association and impairs LCAT activation
por: Weers, Paul M. M., et al.
Publicado: (2011)

Prognostic value of the serum apolipoprotein B to apolipoprotein A-I ratio in metastatic colorectal cancer patients
por: Yang, Dong-Dong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dl7967b9g00n39n295uedejcuh